The global life science and chemical instruments market is set to witness remarkable expansion, reaching an estimated value of USD 47.5 billion in 2024. With a steady compound annual growth rate (CAGR ...

Activist investor Keith Meister will join the board of gene-sequencing maker Illumina , and current board member Scott ...

Activist investor Keith Meister will join the board of gene-sequencing maker Illumina, and current board member Scott ...

Activist investor Keith Meister will join the board of directors of troubled gene-sequencing maker Illumina, and current ...

This A-List features two lists of sequencing instrument providers: eight for NGS instruments and three for Sanger ...

Element Biosciences’ bid to claim a slice of a DNA sequencing technology market dominated by Illumina has been helped by an impressive $277 million financing round backed by a wide range of ...

According to Research by SNS Insider, the growth of the liquid biopsy market is driven by significant technological advancements and a growing preference for minimally invasive procedures.Pune, March ...

Ampli1™ LowPass Kit applications include the characterization and investigation of genomic heterogeneity and evolution in tumor cell populations such as individual circulating tumor cells (CTCs ...

It employs recombinant DNA, DNA sequencing methods, and bioinformatics to sequence, assemble, and analyse the structure and function of genomes. Based on genome-wide association study data from 2. ...